With the SARS-CoV-2 (COVID-19) pandemic, the COVID-19-related angiotensin-converting enzyme 2 (ACE2) has attracted worldwide attention because it is a major receptor that allows the virus to enter human cells[9], while few reports about ACE2 expression and its value in HCC can be seen. Here, ACE2 is linked to hepatocellular carcinoma.